Effect of combination of nitric oxide synthase and cyclooxygenase inhibitors on carrageenan-induced pleurisy in rats

Life Sciences

Volumn 79, Issue 5, 2006, Pages 442-447

  Sakaguchi, Yasue ^a   Shirahase, Hiroaki ^b   Kunishiro, Kazuyoshi ^b   Ichikawa, Atsuko ^a   Kanda, Mamoru ^b   Uehara, Yoshio ^c  

^a Fuji Biomedix Co Ltd   (Japan)

^b Research Laboratories   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Carrageenan induced pleurisy; COX inhibitor; Nitric oxide; NOS inhibitor; PGE2; Rat

Indexed keywords

ALBUMIN; ANTIINFLAMMATORY AGENT; CARRAGEENAN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXUDATE; LEUKOCYTE; MALE; NONHUMAN; PLEURISY; RAT; STATISTICAL SIGNIFICANCE;

ALBUMINS; ANIMALS; CARRAGEENAN; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DRUG INTERACTIONS; EXUDATES AND TRANSUDATES; INDOMETHACIN; LEUKOCYTE COUNT; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE SYNTHASE; NITRITES; PLEURISY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33745001630     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.01.022     Document Type: Article

References (25)

1. Amin A.R., Attur M., and Abramson S.B. Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Current Opinion in Rheumatology 11 3 (1999) 202-209
2. Bucci M., Roviezzo F., Posadas I., Yu J., Parente L., Sessa W.C., Ignarro L.J., and Cirino G. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proceedings of the National Academy of Sciences of the United States of America 102 3 (2005) 904-908
3. Cochran F.R., Selph J., and Sherman P. Insights into the role of nitric oxide in inflammatory arthritis. Medicinal Research Reviews 16 6 (1996) 547-563
4. Cuzzocrea S., Zingarelli B., Hake P., Salzman A.L., and Szabo C. Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radical Biology and Medicine 24 3 (1998) 450-459
5. Cuzzocrea S., Mazzon E., Calabro G., Dugo L., De Sarro A., van De Loo F.A.T., and Caputi A.P. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. American Journal of Respiratory and Critical Care Medicine 162 5 (2000) 1859-1866
6. Farrell A.J., Blake D.R., Palmer R.M., and Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Annals of the Rheumatic Diseases 51 11 (1992) 1219-1222
7. Fletcher D.S., Widmer W.R., Luell S., Christen A., Orevillo C., Shah S., and Visco D. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats. Journal of Pharmacology and Experimental Therapeutics 284 2 (1998) 714-721
8. Forstermann U., and Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedeberg's Archives of Pharmacology 352 4 (1995) 351-364
9. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., and Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nature Medicine 5 6 (1999) 698-701
10. 2 formation in rat carrageenan-induced pleurisy. Prostaglandins 51 1 (1996) 19-33
11. Ialenti A., Ianaro A., Maffia P., Sautebin L., and Di Rosa M. Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. Inflammation Research 49 8 (2000) 411-417
12. McCartney-Francis N.L., Song X., Mizel D.E., and Wahl S.M. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. Journal of Immunology 166 4 (2001) 2734-2740
13. 2 and other cyclic AMP stimulants in J774 macrophages. Biochemical Pharmacology 53 4 (1997) 493-500
14. Paul-Clark M.J., Gilroy D.W., Willis D., Willoughby D.A., and Tomlinson A. Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. Journal of Immunology 166 2 (2001) 1169-1177
15. Pinheiro R.M., and Calixto J.B. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflammation Research 51 12 (2002) 603-610
16. Pozza M., Bettelli C., Magnani F., Mascia M.T., Manzini E., and Calza L. Is neuronal nitric oxide involved in adjuvant-induced joint inflammation?. European Journal of Pharmacology 359 1 (1998) 87-93
17. Sakaguchi Y., Shirahase H., Ichikawa A., Kanda M., Nozaki Y., and Uehara Y. Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice. Life Sciences 75 19 (2004) 2257-2267
18. Salvemini D., Wang Z.Q., Wyatt P.S., Bourdon D.M., Marino M.H., Manning P.T., and Currie M.G. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. British Journal of Pharmacology 118 4 (1996) 829-838
19. St.Clair E.W., Wilkinson W.E., Lang T., Sanders L., Misukonis M.A., Gilkeson G.S., Pisetsky D.S., Granger D.I., and Weinberg J.B. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. Journal of Experimental Medicine 184 3 (1996) 1173-1178
20. Stefanovic-Racic M., Stadler J., and Evans C.H. Nitric oxide and arthritis. Arthritis and Rheumatism 36 8 (1993) 1036-1044
21. Stefanovic-Racic M., Meyers K., Meschter C., Coffey J.W., Hoffman R.A., and Evans C.H. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. Journal of Rheumatology 22 10 (1995) 1922-1928
22. Swierkosz T.A., Mitchell J.A., Warner T.D., Botting R.M., and Vane J.R. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. British Journal of Pharmacology 114 7 (1995) 1335-1342
23. Tanaka S., Matsui T., Murakami T., Ishizuka T., Sugiura M., Kawashima K., and Sugita T. Immunological abnormality associated with the augmented nitric oxide synthesis in adjuvant-induced arthritis. International Journal of Immunopharmacology 20 1-3 (1998) 71-84
24. Tomlinson A., Appleton I., Moore A.R., Gilroy D.W., Willis D., Mitchell J.A., and Willoughby D.A. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. British Journal of Pharmacology 113 3 (1994) 693-698
25. Vermeire K., Thielemans L., Matthys P., and Billiau A. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma. Journal of Leukocyte Biology 68 1 (2000) 119-124